Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Denial of the appropriate cell-matrix interaction in epithelial cells induces apoptosis and is called 'anoikis'. Cancer cells are resistant to anoikis and it is believed that the resistance to anoikis helps promote tumor malignancy especially metastasis. We and others have demonstrated that the expression of tight junction protein claudin-1 is highly upregulated in colorectal cancer (CRC) and helps promote tumor progression and metastasis. However, molecular mechanism/s underlying claudin-1-dependent regulation of CRC progression remains poorly understood. In current study, we have determined that claudin-1 expression modulates anoikis in colon cancer cells to influence colon cancer invasion and thus metastasis. We have further provided data that claudin-1 modulates anoikis in a Src-Akt-Bcl-2-dependent manner. Importantly, claudin-1 physically associates with Src/p-Src in a multiprotein complex that also includes ZO-1, a PDZ-binding tight junction protein. Taken together, our data support the role of claudin-1 in the regulation of CRC progression and suggest that the regulation of anoikis may serve as a key regulatory mechanism in claudin-1-dependent regulation of CRC progression. Our findings are of direct clinical relevance and may open new therapeutic opportunity in colon cancer treatment and/or management.

Original languageEnglish (US)
Article numberbgs275
Pages (from-to)2538-2547
Number of pages10
JournalCarcinogenesis
Volume33
Issue number12
DOIs
StatePublished - Dec 1 2012

Fingerprint

Claudin-1
Anoikis
Colonic Neoplasms
Colorectal Neoplasms
Neoplasm Metastasis
Neoplasms
Zonula Occludens-1 Protein
Tight Junction Proteins
Multiprotein Complexes
Cell Communication
Carrier Proteins
Epithelial Cells
Apoptosis

ASJC Scopus subject areas

  • Cancer Research

Cite this

Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner. / Singh, Amar B.; Sharma, Ashok; Dhawan, Punita.

In: Carcinogenesis, Vol. 33, No. 12, bgs275, 01.12.2012, p. 2538-2547.

Research output: Contribution to journalArticle

@article{245da95fc2cb4b33ac40872bf6697dd7,
title = "Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner",
abstract = "Denial of the appropriate cell-matrix interaction in epithelial cells induces apoptosis and is called 'anoikis'. Cancer cells are resistant to anoikis and it is believed that the resistance to anoikis helps promote tumor malignancy especially metastasis. We and others have demonstrated that the expression of tight junction protein claudin-1 is highly upregulated in colorectal cancer (CRC) and helps promote tumor progression and metastasis. However, molecular mechanism/s underlying claudin-1-dependent regulation of CRC progression remains poorly understood. In current study, we have determined that claudin-1 expression modulates anoikis in colon cancer cells to influence colon cancer invasion and thus metastasis. We have further provided data that claudin-1 modulates anoikis in a Src-Akt-Bcl-2-dependent manner. Importantly, claudin-1 physically associates with Src/p-Src in a multiprotein complex that also includes ZO-1, a PDZ-binding tight junction protein. Taken together, our data support the role of claudin-1 in the regulation of CRC progression and suggest that the regulation of anoikis may serve as a key regulatory mechanism in claudin-1-dependent regulation of CRC progression. Our findings are of direct clinical relevance and may open new therapeutic opportunity in colon cancer treatment and/or management.",
author = "Singh, {Amar B.} and Ashok Sharma and Punita Dhawan",
year = "2012",
month = "12",
day = "1",
doi = "10.1093/carcin/bgs275",
language = "English (US)",
volume = "33",
pages = "2538--2547",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner

AU - Singh, Amar B.

AU - Sharma, Ashok

AU - Dhawan, Punita

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Denial of the appropriate cell-matrix interaction in epithelial cells induces apoptosis and is called 'anoikis'. Cancer cells are resistant to anoikis and it is believed that the resistance to anoikis helps promote tumor malignancy especially metastasis. We and others have demonstrated that the expression of tight junction protein claudin-1 is highly upregulated in colorectal cancer (CRC) and helps promote tumor progression and metastasis. However, molecular mechanism/s underlying claudin-1-dependent regulation of CRC progression remains poorly understood. In current study, we have determined that claudin-1 expression modulates anoikis in colon cancer cells to influence colon cancer invasion and thus metastasis. We have further provided data that claudin-1 modulates anoikis in a Src-Akt-Bcl-2-dependent manner. Importantly, claudin-1 physically associates with Src/p-Src in a multiprotein complex that also includes ZO-1, a PDZ-binding tight junction protein. Taken together, our data support the role of claudin-1 in the regulation of CRC progression and suggest that the regulation of anoikis may serve as a key regulatory mechanism in claudin-1-dependent regulation of CRC progression. Our findings are of direct clinical relevance and may open new therapeutic opportunity in colon cancer treatment and/or management.

AB - Denial of the appropriate cell-matrix interaction in epithelial cells induces apoptosis and is called 'anoikis'. Cancer cells are resistant to anoikis and it is believed that the resistance to anoikis helps promote tumor malignancy especially metastasis. We and others have demonstrated that the expression of tight junction protein claudin-1 is highly upregulated in colorectal cancer (CRC) and helps promote tumor progression and metastasis. However, molecular mechanism/s underlying claudin-1-dependent regulation of CRC progression remains poorly understood. In current study, we have determined that claudin-1 expression modulates anoikis in colon cancer cells to influence colon cancer invasion and thus metastasis. We have further provided data that claudin-1 modulates anoikis in a Src-Akt-Bcl-2-dependent manner. Importantly, claudin-1 physically associates with Src/p-Src in a multiprotein complex that also includes ZO-1, a PDZ-binding tight junction protein. Taken together, our data support the role of claudin-1 in the regulation of CRC progression and suggest that the regulation of anoikis may serve as a key regulatory mechanism in claudin-1-dependent regulation of CRC progression. Our findings are of direct clinical relevance and may open new therapeutic opportunity in colon cancer treatment and/or management.

UR - http://www.scopus.com/inward/record.url?scp=84870355576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870355576&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgs275

DO - 10.1093/carcin/bgs275

M3 - Article

C2 - 22941059

AN - SCOPUS:84870355576

VL - 33

SP - 2538

EP - 2547

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 12

M1 - bgs275

ER -